hospit
children
year
age
amman
jordan
admit
fever
andor
respiratori
symptom
test
middl
east
respiratori
syndrom
coronaviru
merscov
merscov
realtim
rtpcr
rrtpcr
prospect
yearround
viral
surveil
studi
children
year
age
admit
acut
respiratori
symptom
andor
fever
march
septemb
enrol
governmentrun
hospit
albashir
amman
jordan
clinic
demograph
data
includ
antibiot
use
collect
combin
nasalthroat
swab
collect
aliquot
frozen
specimen
aliquot
ship
vanderbilt
univers
center
diseas
control
prevent
cdc
test
rrtpcr
merscov
test
vanderbilt
none
posit
merscov
neg
find
larg
sampl
young
jordanian
children
hospit
fever
andor
respiratori
symptom
suggest
merscov
wide
circul
amman
jordan
period
prospect
activ
surveil
occur
first
document
merscov
outbreak
middl
east
region
recent
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
first
discov
septemb
led
enhanc
surveil
effort
throughout
world
detect
new
case
time
manner
better
understand
transmiss
pathogenesi
viru
coronavirus
divers
group
positivestrand
rna
virus
commonli
infect
respiratori
gastrointestin
tract
mammal
bird
human
coronavirus
commonli
associ
mild
respiratori
ill
caus
sever
ill
sever
acut
respiratori
syndrom
sar
coronaviru
genet
sequenc
data
indic
merscov
betacoronaviru
close
relat
two
bat
coronavirus
distinct
human
coronavirus
includ
sarscov
novemb
world
health
organ
inform
total
laboratoryconfirm
case
infect
merscov
includ
death
case
origin
follow
countri
middl
eastern
countri
date
jordan
qatar
saudi
arabia
unit
arab
emir
uae
franc
germani
spain
itali
tunisia
unit
kingdom
also
report
laboratoryconfirm
case
first
known
merscov
infect
detect
retrospect
occur
april
jordan
base
confirm
case
date
clinic
syndrom
consist
febril
ill
pneumonia
well
renal
failur
patient
major
report
case
adult
case
fatal
case
occur
cluster
one
cluster
involv
two
case
fatal
occur
near
amman
jordan
zarga
km
distanc
april
store
sampl
two
case
one
hospit
worker
one
student
test
posit
merscov
retrospect
cluster
tempor
associ
case
ill
among
hospit
worker
sever
cluster
suggest
human
transmiss
although
risk
sustain
transmiss
unknown
epidemiolog
merscov
includ
potenti
distribut
among
paediatr
case
sever
acut
respiratori
ill
ari
character
critic
question
whether
case
identifi
thu
far
merscov
infect
whether
viru
circul
wide
undetect
interest
light
epidemiolog
sarscov
infect
children
year
age
gener
milder
mortal
hospit
determin
whether
merscov
present
among
young
paediatr
ari
case
occurr
zarga
jordan
merscov
cluster
test
upper
respiratori
tract
specimen
collect
prospect
studi
paediatr
ari
hospit
amman
jordan
march
septemb
prospect
yearround
viral
surveil
studi
children
year
admit
respiratori
symptom
andor
fever
commenc
march
al
basheer
hospit
main
governmentrun
hospit
referr
centr
amman
jordan
paediatr
hospit
bed
catchment
approxim
one
million
person
popul
subject
enrol
day
per
week
sundaythursday
approxim
month
march
septemb
consent
obtain
child
clinic
symptom
admiss
hospit
demograph
inform
collect
parent
interview
medic
record
review
determin
hospit
cours
clinic
outcom
institut
review
board
approv
obtain
vanderbilt
univers
jordan
univers
jordanian
ministri
health
nasal
throat
swab
collect
combin
transport
medium
remel
lenexa
ks
usa
aliquot
magmax
tm
lysisbind
solut
concentr
life
technolog
grand
island
ny
usa
snap
frozen
store
origin
lysi
buffer
aliquot
ship
vanderbilt
univers
dri
ice
test
realtim
rtpcr
rrtpcr
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
influenza
b
parainfluenza
viru
one
two
three
sampl
test
vanderbilt
virus
detect
sent
cdc
merscov
test
sampl
previous
test
respiratori
virus
test
merscov
vanderbilt
vanderbilt
pcr
testingnucl
acid
extract
realtim
rtpcr
rrtpcr
test
rna
extract
thaw
specimen
accord
manufactur
protocol
tm
viral
rna
isol
kit
life
technolog
primer
probe
synthes
commerci
supplier
eurofin
mwg
operon
huntsvil
al
usa
base
previous
describ
sequenc
rrtpcr
assay
design
target
upe
region
merscov
genom
posit
control
target
sequenc
upe
assay
flank
nucleotid
c
bp
total
synthes
commerci
sourc
genscript
piscataway
nj
usa
clone
plasmid
onestep
rrtpcr
reaction
prepar
use
agpathid
onestep
rtpcr
kit
life
technolog
accord
manufactur
instruct
nm
forward
revers
primer
nm
probe
cycl
paramet
min
min
cycl
fluoresc
data
collect
annealingextens
step
specimen
test
first
upe
assay
use
rna
potenti
posit
retest
use
assay
upe
assay
repeat
rna
culturecel
virus
vero
cell
maintain
optimem
life
technolog
media
supplement
fetal
calf
serum
gentamicin
amphotericin
b
glutamin
tylosin
viru
work
perform
biosafeti
level
bsl
three
laboratori
follow
ibcapprov
procedur
viru
recoveri
vero
cell
plate
flask
next
day
media
remov
ml
ad
back
frozen
specimen
aliquot
thaw
ice
specimen
pb
mock
ad
flask
flask
maintain
co
min
rock
everi
min
ml
optimem
ad
flask
flask
return
incub
flask
examin
cytopath
effect
cpe
everi
h
cdc
pcr
testingbriefli
total
nucleic
acid
tna
extract
swab
specimen
use
nuclisen
easymag
biom
erieux
durham
nc
usa
specimen
test
three
discret
rrtpcr
assay
upe
assay
describ
two
inhous
develop
assay
target
merscov
nucleocapsid
gene
assay
perform
final
reaction
volum
contain
sampl
tna
extract
use
invitrogen
superscript
iii
platinum
onestep
quantit
rtpcr
system
life
technolog
appli
biosystem
fast
dx
realtim
pcr
instrument
life
technolog
posit
test
result
assign
sampl
gener
welldefin
fluoresc
curv
cross
threshold
within
cycl
assay
investig
posit
merscov
rna
transcript
templat
neg
nucleasefre
water
control
includ
run
monitor
assay
perform
sampl
also
test
rrtpcr
presenc
human
ribonucleas
p
gene
control
specimen
qualiti
subject
enrol
march
septemb
specimen
avail
pcr
test
merscov
clinic
data
avail
median
age
month
male
underli
medic
condit
requir
oxygen
diagnosi
pneumonia
admit
icu
addit
attend
day
care
expos
smoker
major
father
employ
mother
finish
primari
educ
secondari
educ
colleg
respect
major
children
live
amman
howev
children
live
surround
citi
includ
zarqa
children
tabl
includ
demograph
data
diagnos
outcom
data
entir
group
test
site
specimen
prospect
test
virus
rrtpcr
assay
rna
per
reaction
neg
final
specimen
retest
use
cdc
merscov
nucleocapsid
primer
probe
provid
vanderbilt
also
neg
four
specimen
inocul
vero
cell
three
sampl
show
evid
bacteri
fungal
contamin
within
h
follow
inocul
discard
recultur
due
lack
adequ
amount
sampl
cell
inocul
fourth
sampl
monitor
day
passag
new
cultur
follow
addit
day
cpe
detect
comparison
among
three
group
made
use
kruskalw
test
pearson
chisquar
test
continu
variabl
categor
variabl
respect
despit
close
proxim
first
document
merscov
outbreak
zarga
april
detect
merscov
among
children
year
age
hospit
ari
time
period
amman
jordan
km
away
young
children
known
sourc
respiratori
viral
transmiss
therefor
neg
find
epidemiolog
suggest
merscov
may
wide
circul
nearbi
metropolitan
amman
jordan
interv
import
find
remain
uncertainti
whether
confirm
merscov
case
like
detect
due
sever
ill
full
extent
merscov
circul
wide
caus
mild
ill
nevertheless
surveil
still
need
arabian
peninsula
neighbour
countri
monitor
current
circul
possibl
emerg
widespread
transmiss
major
merscov
case
report
date
adult
common
symptom
includ
fever
cough
short
breath
high
proport
case
result
death
four
specimen
test
preliminarili
posit
merscov
upe
rrtpcr
assay
albeit
high
c
valu
howev
test
confirm
falseposit
result
illustr
assay
even
experienc
laboratori
fals
posit
occur
thu
given
public
health
import
viru
confirmatori
test
perform
provision
testposit
specimen
studi
limit
fact
hospit
children
ari
enrol
thu
may
miss
milder
case
merscov
infect
among
outpati
children
exampl
children
year
age
infect
sarscov
report
milder
diseas
compar
older
children
adult
nose
throat
swab
obtain
acut
respiratori
diseas
test
sensit
specimen
type
detect
merscov
current
unknown
cdc
recommend
collect
respiratori
specimen
differ
site
differ
stage
ill
lower
respiratori
tract
specimen
priorit
exist
routin
surveil
middl
east
elsewher
typic
focus
nosethroat
swab
sampl
test
neg
viru
sent
cdc
test
therefor
may
miss
instanc
merscov
coinfect
respiratori
sampl
collect
first
merscov
cluster
occur
jordan
april
test
howev
strength
studi
test
almost
children
hospit
ari
symptom
merscov
note
anoth
studi
describ
lack
detect
merscov
nasal
swab
group
french
hajj
pilgrim
return
franc
despit
high
rate
respiratori
symptom
conclus
neg
find
suggest
merscov
wide
circul
amman
jordan
period
prospect
activ
surveil
occur
first
document
outbreak
merscov
region
studi
confirm
valu
prospect
viral
surveil
infrastructur
facilit
rapid
respons
emerg
pathogen
